LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)
CNY 7.25
(-0.82%)
CNY 7.25
(-0.82%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 369.72 Million CNY | 5.51% |
| 2022 | 350.4 Million CNY | 35.38% |
| 2021 | 258.83 Million CNY | 0.2% |
| 2020 | 258.32 Million CNY | -9.93% |
| 2019 | 286.81 Million CNY | 18.85% |
| 2018 | 241.32 Million CNY | 22.74% |
| 2017 | 196.6 Million CNY | 2.83% |
| 2016 | 191.2 Million CNY | 20.02% |
| 2015 | 159.31 Million CNY | 15.45% |
| 2014 | 137.99 Million CNY | 10.63% |
| 2013 | 124.73 Million CNY | -16.98% |
| 2012 | 150.24 Million CNY | 7.25% |
| 2011 | 140.08 Million CNY | 63.62% |
| 2010 | 85.61 Million CNY | 7.17% |
| 2009 | 79.89 Million CNY | 5.13% |
| 2008 | 75.99 Million CNY | 57.9% |
| 2007 | 48.12 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 379.86 Million CNY | 2.75% |
| 2024 Q3 | 405.49 Million CNY | -3.02% |
| 2024 Q2 | 418.13 Million CNY | 10.07% |
| 2023 Q3 | 379.71 Million CNY | -4.31% |
| 2023 FY | 369.72 Million CNY | 5.51% |
| 2023 Q2 | 396.81 Million CNY | -5.28% |
| 2023 Q4 | 369.72 Million CNY | -2.63% |
| 2023 Q1 | 418.94 Million CNY | 19.56% |
| 2022 Q2 | 346.53 Million CNY | 18.79% |
| 2022 Q4 | 350.4 Million CNY | 21.35% |
| 2022 FY | 350.4 Million CNY | 35.38% |
| 2022 Q1 | 291.71 Million CNY | 12.7% |
| 2022 Q3 | 288.76 Million CNY | -16.67% |
| 2021 FY | 258.83 Million CNY | 0.2% |
| 2021 Q1 | 240.15 Million CNY | -7.03% |
| 2021 Q2 | 280.73 Million CNY | 16.9% |
| 2021 Q3 | 285.32 Million CNY | 1.64% |
| 2021 Q4 | 258.83 Million CNY | -9.29% |
| 2020 Q2 | 341.06 Million CNY | 2.83% |
| 2020 Q1 | 331.67 Million CNY | 15.64% |
| 2020 Q4 | 258.32 Million CNY | -13.09% |
| 2020 Q3 | 297.23 Million CNY | -12.85% |
| 2020 FY | 258.32 Million CNY | -9.93% |
| 2019 Q4 | 286.81 Million CNY | 11.61% |
| 2019 FY | 286.81 Million CNY | 18.85% |
| 2019 Q2 | 241.87 Million CNY | 2.78% |
| 2019 Q1 | 235.33 Million CNY | -2.48% |
| 2019 Q3 | 256.98 Million CNY | 6.25% |
| 2018 Q3 | 222.96 Million CNY | 5.77% |
| 2018 Q1 | 191.17 Million CNY | -2.76% |
| 2018 FY | 241.32 Million CNY | 22.74% |
| 2018 Q4 | 241.32 Million CNY | 8.23% |
| 2018 Q2 | 210.8 Million CNY | 10.27% |
| 2017 Q3 | 239.93 Million CNY | 0.87% |
| 2017 Q4 | 196.6 Million CNY | -18.06% |
| 2017 FY | 196.6 Million CNY | 2.83% |
| 2017 Q1 | 209.41 Million CNY | 9.52% |
| 2017 Q2 | 237.87 Million CNY | 13.59% |
| 2016 Q2 | 179.09 Million CNY | 8.72% |
| 2016 FY | 191.2 Million CNY | 20.02% |
| 2016 Q4 | 191.2 Million CNY | 1.47% |
| 2016 Q3 | 188.43 Million CNY | 5.22% |
| 2016 Q1 | 164.73 Million CNY | 3.41% |
| 2015 Q4 | 159.31 Million CNY | 30.61% |
| 2015 Q1 | 115.66 Million CNY | -16.18% |
| 2015 Q2 | 135.02 Million CNY | 16.74% |
| 2015 Q3 | 121.97 Million CNY | -9.67% |
| 2015 FY | 159.31 Million CNY | 15.45% |
| 2014 Q4 | 137.99 Million CNY | -4.96% |
| 2014 FY | 137.99 Million CNY | 10.63% |
| 2014 Q3 | 145.2 Million CNY | -2.19% |
| 2014 Q2 | 148.44 Million CNY | 4.12% |
| 2014 Q1 | 142.56 Million CNY | 14.3% |
| 2013 Q3 | 144.68 Million CNY | 13.85% |
| 2013 FY | 124.73 Million CNY | -16.98% |
| 2013 Q1 | 129.37 Million CNY | -13.89% |
| 2013 Q2 | 127.09 Million CNY | -1.77% |
| 2013 Q4 | 124.73 Million CNY | -13.79% |
| 2012 Q3 | 122.43 Million CNY | -4.72% |
| 2012 Q2 | 128.5 Million CNY | 0.87% |
| 2012 Q1 | 127.39 Million CNY | -9.06% |
| 2012 FY | 150.24 Million CNY | 7.25% |
| 2012 Q4 | 150.24 Million CNY | 22.71% |
| 2011 Q4 | 140.08 Million CNY | 45.76% |
| 2011 Q3 | 96.1 Million CNY | -18.22% |
| 2011 FY | 140.08 Million CNY | 63.62% |
| 2011 Q2 | 117.52 Million CNY | 0.0% |
| 2010 FY | 85.61 Million CNY | 7.17% |
| 2010 Q4 | 85.61 Million CNY | 0.0% |
| 2009 FY | 79.89 Million CNY | 5.13% |
| 2008 FY | 75.99 Million CNY | 57.9% |
| 2007 FY | 48.12 Million CNY | 0.0% |